1h Free Analyst Time
The travel vaccines market is forecasted to grow by USD 3.97 billion during 2023-2028, accelerating at a CAGR of 8.64% during the forecast period. The report on the travel vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in global migration, increase in awareness of vaccine-preventable diseases among travelers, and mandatory regulations on immunization prior to issuing visas.
The travel vaccines market is segmented as below:
By Disease Type
- Influenza
- Diptheria
- Hepatitis
- Typhoid and others
By End-user
- Adult vaccines
- Pediatric vaccines
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the travel vaccines market covers the following areas:
- Travel vaccines market sizing
- Travel vaccines market forecast
- Travel vaccines market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Disease Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The analyst recognizes the following companies as the key players in the global travel vaccines market: Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is changes in demographic profile of travelers globally.'
According to the report, one of the major drivers for this market is the increase in global migration.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Altimmune Inc.
- AstraZeneca Plc
- Bavarian Nordic AS
- Bharat Biotech Ltd.
- CSL Ltd.
- Dynavax Technologies Corp.
- Emergent BioSolutions Inc.
- GlaxoSmithKline Plc
- KM Biologics Co. Ltd.
- LG Chem Ltd.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Serum Institute of India Pvt. Ltd.
- Shenzhen Kangtai Biological Products Co. Ltd.
- SK Chemicals Co. Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Valneva SE
